Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs

被引：0
|
作者：
Katarzyna Kolasa
Krzysztof M. Zwolinski
Zoltan Kalo
Tomasz Hermanowski
机构：
[1] Nicolaus Copernicus University Collegium Medicum,Department of Health Economics
[2] Warsaw University of Technology Business School,Advanced Management Training Programme in Pharmacoeconomics, Pharmaceutical Marketing and Law
[3] Eötvös Loránd University (ELTE),Department of Health Policy & Health Economics, Faculty of Social Sciences
来源：
Orphanet Journal of Rare Diseases | / 11卷
关键词：
Health Technology Assessment; Orphan Drug; Discrete Choice Experiment; Economic Criterion; Budget Impact Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [1] Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
    Kolasa, Katarzyna
    Zwolinski, Krzysztof M.
    Kalo, Zoltan
    Hermanowski, Tomasz
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [2] Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs
    C. Schey
    P. F. M. Krabbe
    M. J. Postma
    M. P. Connolly
    [J]. Orphanet Journal of Rare Diseases, 12
  • [3] Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs
    Schey, C.
    Krabbe, P. F. M.
    Postma, M. J.
    Connolly, M. P.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [4] MULTI-CRITERIA DECISION ANALYSIS (MCDA): TESTING A PROPOSED MCDA MODEL FOR ORPHAN DRUGS
    Schey, C.
    Connolly, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A556 - A556
  • [5] Multiple-Criteria Decision Analysis for Assessments of Chemical Alternatives (MCDA-ACA)
    London, Rachel L.
    Glüge, Juliane
    Scheringer, Martin
    [J]. Environmental Science and Technology, 2024, 58 (43): : 19315 - 19324
  • [6] IMPLEMENTATION OF COMPREHENSIVE CRITERIA FOR DECISION MAKING PROCESS OF PRICING AND REIMBURSEMENT IN ALGERIA
    Aissaoui, A.
    Khelef, R.
    Ahmed, N.
    Redouane, S.
    Mokhtaria, B.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S297 - S297
  • [7] REAL-WORLD APPLICATION OF MULTIPLE CRITERIA DECISION ANALYSIS (MCDA) FOR EVALUATING ORPHAN DRUGS (ODS) IN EUROPE
    Franceschini, M.
    Soon, J.
    Han, Y.
    [J]. VALUE IN HEALTH, 2020, 23 : S707 - S707
  • [8] A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN RARE DISEASES: REIMBURSEMENT CRITERIA FOR ORPHAN DRUGS IN SPAIN (FINMHU-MCDA STUDY)
    de Andres-Nogales, F.
    Cruz, E.
    Calleja, M. A.
    Delgado, O.
    Gorgas Torner, M. Q.
    Espin, J.
    Mestre-Ferrandiz, J.
    Palau, F.
    Ancochea, A.
    Arce, R.
    Dominguez-Hernandez, R.
    Casado, M. A.
    [J]. VALUE IN HEALTH, 2020, 23 : S706 - S707
  • [9] Comparison of Efficiency of Accelerating Admixtures for Concrete Using Multiple-Criteria Decision Analysis (MCDA)
    Pizon, Jan
    Lazniewska-Piekarczyk, Beata
    [J]. 3RD WORLD MULTIDISCIPLINARY CIVIL ENGINEERING, ARCHITECTURE, URBAN PLANNING SYMPOSIUM (WMCAUS 2018), 2019, 471
  • [10] A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
    de Andres-Nogales, Fernando
    Cruz, Encarnacion
    Calleja, Miguel Angel
    Delgado, Olga
    Gorgas, Maria Queralt
    Espin, Jaime
    Mestre-Ferrandiz, Jorge
    Palau, Francesc
    Ancochea, Alba
    Arce, Rosabel
    Dominguez-Hernandez, Raquel
    Casado, Miguel Angel
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
1234